News

MannKind's Afrezza Inhalation Powder Approved for Indian Market

MannKind's Afrezza Inhalation Powder Approved for Indian Market

MannKind's Exciting Milestone in Diabetes Care

MannKind Corporation has recently achieved a significant milestone by receiving approval for Afrezza (insulin human) Inhalation Powder for adults in India. This approval comes from the Central Drugs Standard Control Organisation (CDSCO) and marks an important development in the global fight against diabetes, especially in a country where the disease is a pressing concern.

Addressing the Diabetes Epidemic

India grapples with one of the highest burdens of diabetes in the world, with over 74 million individuals currently living with this chronic condition. The International Diabetes Federation has projected that this number could rise to 643 million globally by 2030, highlighting the urgency of effective treatment options. MannKind's inhaled insulin product offers a non-injectable alternative, aiming to improve glycemic control while making diabetes management more convenient for patients.

The Approval Journey

The journey toward approval of Afrezza in India reflects the company's persistent efforts and strategic partnerships. The recent endorsement follows earlier approvals in markets such as the United States and Brazil, showcasing MannKind's commitment to expanding access to this innovative therapy worldwide. Michael Castagna, PharmD, the CEO of MannKind Corporation, expressed enthusiasm about this breakthrough and the impact it could have on patients in India.

Partnership with Cipla Ltd.

In May 2018, MannKind entered an exclusive agreement with Cipla Ltd., a leading global pharmaceutical firm, to manage the marketing and distribution of Afrezza in India. This partnership underscores the importance of collaboration in the healthcare sector, as Cipla leads regulatory efforts and marketing initiatives to ensure the successful launch of Afrezza.

Understanding Afrezza's Impact

Afrezza is a rapid-acting inhaled human insulin designed to enhance glycemic control for adults with diabetes mellitus. Its innovative delivery system facilitates a convenient non-injectable method, making it easier for patients to integrate into their daily routines. Not only does this approach help alleviate the discomfort associated with traditional insulin injections, but it also empowers patients in managing their condition more effectively.

Safety and Usage Considerations

While Afrezza offers promising benefits, it is essential to consider its limitations. The product is not recommended for people experiencing diabetic ketoacidosis or those with chronic lung diseases. Additional safety concerns include the potential risk of acute bronchospasm in patients with pre-existing respiratory conditions. As such, healthcare providers are advised to conduct thorough assessments before prescribing Afrezza, ensuring it aligns with patients' health needs.

About MannKind Corporation

MannKind Corporation is at the forefront of developing and commercializing inhaled therapeutic products aimed at fulfilling the unmet medical needs of individuals facing endocrine and lung diseases. Their commitment to innovation and patient-centric solutions drives their mission to enhance the quality of life for those living with chronic conditions. Through advanced formulations and engineering solutions, MannKind continues to explore new avenues in therapeutic delivery, especially for conditions like diabetes, pulmonary fibrosis, and other serious ailments.

Frequently Asked Questions

What is Afrezza?

Afrezza is an inhaled human insulin product developed by MannKind Corporation, designed for improving glycemic control in adults with diabetes.

How does Afrezza work?

Afrezza works as a rapid-acting insulin that is inhaled, serving as a non-injectable alternative to traditional insulin therapy.

Who is responsible for marketing Afrezza in India?

Cipla Ltd. is responsible for the marketing and distribution of Afrezza in India, having entered an exclusive partnership with MannKind Corporation.

What are the possible side effects of Afrezza?

The most common adverse reactions to Afrezza include hypoglycemia, cough, and throat irritation, with specific safety warnings for patients with chronic lung disease.

Why was Afrezza approved in India?

Afrezza was approved in India to provide an innovative treatment option for diabetes management, addressing a significant healthcare need in the country.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Clarivate Integrates Trademark Data with Microsoft AI

Updated Category News Views 124

You know, the market's all abuzz with AI this, AI that. But today, we're getting a glimpse at something that isn't just hyped-up vaporware; it's actually useful. Clarivate Plc (NYSE:CLVT), which has carved a niche in transformative intelligence, is teaming up with Microsoft to slide their CompuMark trademark data into Microsoft Copilot via something they call IPOne. It's...

Continue Reading
UFC Gym Expands, Opening Murfreesboro Location Soon

Updated Category News Views 137

UFC GYM Targets the Heart of Murfreesboro They're doing it again—UFC GYM's tossing another gym into the mix, folks! This time, it's Murfreesboro, Tennessee, catching the brand's punchy, high-energy splash. Don't mistake this for just another big-box, bench-press-jamboree. Their doors swing open come November 14, and this ain't some punk move. We're talking a whopping...

Continue Reading
Urenco's LEU+ Boosts Future Nuclear Reactor Options

Updated Category News Views 139

Urenco's Leap Forward with LEU+ Well, look who’s shaking up the nuclear scene—Urenco USA, that’s who. They’ve just churned out their first cylinder of low-enriched uranium plus (LEU+) at the National Enrichment Facility in Eunice, New Mexico. This isn’t just any regular Tuesday of uranium talk; it marks a seismic shift for nuclear fuel options in the Western...

Continue Reading
StackRails Unleashes AI Power with Contextual Clarity

Updated Category News Views 25

AI's Blind Spots Exposed Let's get this straight—plugging AI into enterprise coding projects without context is like sending a blindfolded sprinter onto a city's marathon route. Sure, they'll move, but who knows what havoc they'll wreak along the way? That's where StackRails steps up to the plate, aiming to dispel the chaos with a robust grip on the bigger picture. The...

Continue Reading
Zensar Sees Solid Revenue Growth in Q2FY27

Updated Category News Views 112

Zensar's Q2 Performance: Growth Amid Shifting Sands Is Zensar Technologies quietly carving a spot for itself in the cutthroat tech marketplace, or are we just seeing a temporary glimmer during a complex market scenario? With a constant currency growth rate of 4.1% in Q2FY27, Zensar sure seems to have gotten something right. But does this mean they’ve got the long-term...

Continue Reading
Maya Mobile Wins Best Global Roaming Services 2026

Updated Category News Views 52

Travelers Speak: Maya Tops Global Roaming It's not every day that you see the travel community collectively high-five a company, but that's precisely what happened with Maya Mobile. These folks just snagged the Best Global Roaming Services title at the TripZilla Excellence Awards 2026, and it's not just fluff—it's voted by travelers. This ain't your typical pat on the...

Continue Reading
Waters Acquires MOBILion: Ion Mobility Meets AI

Updated Category News Views 0

MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...

Continue Reading
Webull Faces Class Action Over Alleged Misleading Disclosures

Updated Category News Views 46

Webull's Disclosure Disaster: A New Chapter Unfolds This isn't just any ordinary day in the world of stocks—Webull Corporation (NASDAQ:BULL) is under the gun, facing a securities fraud class action lawsuit hotter than a frying pan. When lines blur between marketing bravado and operational reality, things tend to sizzle over—and that's exactly where Webull finds itself...

Continue Reading
Winter Roof Woes: How to Handle Ice and Snow Load

Updated Category News Views 112

Understanding Roof Load Limits You don't have to be in the roofing business to know that Central NY doesn't mess around when winter hits. Michael Majeski, a name trusted in Watertown, NY, is sounding the alarm on how snow and ice can either shake a roof or break it. Talking about roof 'load limits' might sound all fancy, but in plain talk, it's about knowing when your...

Continue Reading
Restorative Getaways Aid Grieving Families, Offers Relief

Updated Category News Views 58

Finding Solace in Change: The Power of Stepping Away Grieving a lost child. It’s a trip to hell and back, and for many families, the journey feels endless. The press of everyday life—bills, jobs, commutes—offers no mercy. At times, stepping out of the blur might be the prime move toward healing, and that's where restorative getaways step in. Escaping the Everyday...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Announcements and Market Insights

Updated Category News Views 288

Companies Reporting Earnings Before The Market Opens Various companies are preparing for their quarterly earnings reports, each with expectations that could impact their stock performance in the market. For example, Bank of Hawaii is anticipated to report quarterly earnings of $1.05 per share on revenue of approximately $174.39 million. Similarly, Business First...

Continue Reading
Innovative Marketplace by SendCutSend Transforms Entrepreneurship

Updated Category News Views 404

Revolutionizing Entrepreneurship with SendCutSend Marketplace SendCutSend, an innovative U.S.-based manufacturer specializing in custom sheet metal solutions, has unveiled its new platform, the SendCutSend Marketplace. This strategic move is designed to empower entrepreneurs and small businesses to transform their creative ideas into profitable ventures with ease. What is...

Continue Reading
Robin Energy Ltd. Secures $7 Million in Latest Offering

Updated Category News Views 250

Robin Energy Ltd. Secures Funding Through Offering Robin Energy Ltd. (NASDAQ: RBNE) has announced a significant development, recently entering into a securities purchase agreement with a prominent institutional investor. This agreement allows Robin Energy to sell 6,540,000 common shares or pre-funded warrants, with an offering price set at $1.07 per share and $1.069 per...

Continue Reading
Petrus Resources Launches Exciting Dividend Reinvestment Initiative

Updated Category News Views 243

Petrus Resources Introduces New Dividend Reinvestment Plan Petrus Resources Ltd. (TSX: PRQ) is thrilled to unveil its latest initiative aimed at enhancing shareholder value: a Dividend Reinvestment Plan (DRIP). This program affords eligible shareholders the unique opportunity to reinvest their cash dividends, a move that is expected to significantly benefit both...

Continue Reading
US Treasury Yields Soar After Jobs Report Sparks Concerns

Updated Category News Views 187

Impact of Recent Jobs Data on US Treasury Yields A recent jobs report from the U.S. has sent shockwaves through the financial markets. The data indicated a stronger-than-expected addition of positions, leading to significant changes in Treasury yields. As investors dissect the implications, the prospect of the benchmark 10-year yield reaching the 5% mark is raising alarms...

Continue Reading